Literature DB >> 12517904

Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Lisa Saiman1, Jane L Burns, Davise Larone, Yunhua Chen, Elizabeth Garber, Susan Whittier.   

Abstract

Accurate identification of gram-negative bacilli from cystic fibrosis (CF) patients is essential. Only 57% (108 of 189) of nonmucoid strains and 40% (24 of 60) of mucoid strains were definitively identified as Pseudomonas aeruginosa with MicroScan Autoscan. Most common misidentifications were Pseudomonas fluorescens-Pseudomonas putida (i.e., the strain was either P. fluorescens or P. putida, but the system did not make the distinction and yielded the result P. fluorescens/putida) and Alcaligenes spp. Extending the incubation to 48 h improved identification, but 15% of isolates remained misidentified. The MicroScan Autoscan system cannot be recommended for the identification of P. aeruginosa isolates from CF patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517904      PMCID: PMC149561          DOI: 10.1128/JCM.41.1.492-494.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social settings.

Authors:  L Saiman; N Macdonald; J L Burns; N Hoiby; D P Speert; D Weber
Journal:  Am J Infect Control       Date:  2000-10       Impact factor: 2.918

2.  Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  J L Burns; L Saiman; S Whittier; J Krzewinski; Z Liu; D Larone; S A Marshall; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2001-04       Impact factor: 2.803

3.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.

Authors:  L Saiman; F Mehar; W W Niu; H C Neu; K J Shaw; G Miller; A Prince
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

5.  Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.

Authors:  C van Pelt; C M Verduin; W H Goessens; M C Vos; B Tümmler; C Segonds; F Reubsaet; H Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  J L Burns; L Saiman; S Whittier; D Larone; J Krzewinski; Z Liu; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.

Authors:  J D McMenamin; T M Zaccone; T Coenye; P Vandamme; J J LiPuma
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

8.  Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.

Authors:  D B Shelly; T Spilker; E J Gracely; T Coenye; P Vandamme; J J LiPuma
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

9.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 10.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

View more
  11 in total

Review 1.  Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Authors:  Melissa B Miller; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

Review 2.  Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli.

Authors:  Caroline M O'hara
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.

Authors:  Juyan Zhou; Elizabeth Garber; Manisha Desai; Lisa Saiman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Validation of Vitek 2 nonfermenting gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting gram-negative rods from patients with cystic fibrosis.

Authors:  Ines Otto-Karg; Stefanie Jandl; Tobias Müller; Beate Stirzel; Matthias Frosch; Helge Hebestreit; Marianne Abele-Horn
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

5.  Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells.

Authors:  Hye Jin Choi; Chan Hee Seo; Seong Hwan Park; Hyun Yang; Kee Hun Do; Juil Kim; Hyung-Kab Kim; Duk-Hwa Chung; Jung Hoon Ahn; Yuseok Moon
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

Review 6.  Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors:  Christopher H Goss; Jane L Burns
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

7.  PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.

Authors:  Theodore Spilker; Tom Coenye; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

8.  Evaluation of a scanner-assisted colorimetric MIC method for susceptibility testing of gram-negative fermentative bacteria.

Authors:  Mokhlasur Rahman; Inger Kühn; Motiur Rahman; Barbro Olsson-Liljequist; Roland Möllby
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

9.  Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis.

Authors:  Xuan Qin; Julia Emerson; Jenny Stapp; Lynn Stapp; Patrick Abe; Jane L Burns
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology.

Authors:  John E Moore; John McCaughan; Jacqueline C Rendall; Beverley C Millar
Journal:  Br J Biomed Sci       Date:  2022-06-08       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.